RVL Pharmaceuticals PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| RVLPQ | VXL.V | RLMD | ACTI.ST | RVX.TO | REGN | |
|---|---|---|---|---|---|---|
| Market cap | 1.11K | 438.24K | 444.81M | 101.09M | 27.54M | 96.28B |
| P/E (TTM) | — | 0.7 | — | — | — | 20.6 |
| Forward P/E | 0.0 | — | -10.2 | — | — | 13.2 |
| Price/book | 0.0 | 0.4 | 2.2 | 2.7 | -0.2 | 2.8 |
| Dividend yield | — | — | — | — | — | 0.40% |
| 1-year change | 0.00% | −33.33% | +59.77% | −42.74% | −20.00% | +43.87% |
| Today | 0.00% | +10.00% | −2.34% | +4.21% | +6.67% | −4.39% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All RVLPQ news ›RVL Pharmaceuticals Announces Santen Obtains Manufacturing and Marketing Approval in Japan for UPNEEQ ®? Mini Ophthalmic Solution 0.1%
Published on 01/08/2026 at 07:51 am EST The product was approved in the US by the FDA in July 2020. Low-lying lids may be related to conditions such as stroke and/or brain aneurysm, Horner syndrome, myasthenia gravis, loss of the ability…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.